Mesa Laboratories (NASDAQ:MLAB) CAO Lyndsey Elizabeth Crennen Sells 442 Shares

Mesa Laboratories, Inc. (NASDAQ:MLAB) CAO Lyndsey Elizabeth Crennen sold 442 shares of the business’s stock in a transaction on Monday, June 22nd. The shares were sold at an average price of $89.50, for a total transaction of $39,559.00. Following the sale, the chief accounting officer directly owned 2,020 shares in the company, valued at $180,790. This trade represents a 17.95% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. The sale was made to cover tax withholding obligations related to the vesting of equity awards.

Lyndsey Elizabeth Crennen also recently made the following trade(s):

• On Tuesday, June 16th, Lyndsey Elizabeth Crennen sold 118 shares of Mesa Laboratories stock. The shares were sold at an average price of $101.27, for a total value of $11,949.86.

Mesa Laboratories Stock Performance

Shares of MLAB stock opened at $91.97 on Wednesday. The business has a fifty day moving average of $101.87 and a 200 day moving average of $91.09. Mesa Laboratories, Inc. has a 1 year low of $55.45 and a 1 year high of $113.99. The company has a debt-to-equity ratio of 0.78, a current ratio of 1.72 and a quick ratio of 1.29. The firm has a market capitalization of $507.67 million, a price-to-earnings ratio of 76.64 and a beta of 0.94.

Mesa Laboratories (NASDAQ:MLAB) last posted its quarterly earnings results on Wednesday, May 27th. The medical instruments supplier reported $1.53 earnings per share for the quarter, missing the consensus estimate of $1.78 by ($0.25). Mesa Laboratories had a net margin of 2.69% and a return on equity of 20.96%. The firm had revenue of $63.72 million for the quarter, compared to analysts’ expectations of $65.21 million. During the same quarter in the previous year, the firm posted ($1.31) EPS.

Mesa Laboratories Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Monday, June 15th. Investors of record on Friday, May 29th were issued a $0.16 dividend. This represents a $0.64 annualized dividend and a yield of 0.7%. The ex-dividend date was Friday, May 29th. Mesa Laboratories’s dividend payout ratio is 53.33%.

Wall Street Analysts Forecast Growth

Separately, Weiss Ratings downgraded Mesa Laboratories from a “sell (d+)” rating to a “sell (d)” rating in a research report on Wednesday, June 3rd. Two equities research analysts have rated the stock with a Hold rating and one has given a Sell rating to the company. According to MarketBeat, the stock presently has an average rating of “Reduce” and a consensus price target of $94.00.

Hedge Funds Weigh In On Mesa Laboratories

Several institutional investors and hedge funds have recently modified their holdings of the business. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its holdings in Mesa Laboratories by 4.9% during the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 3,068 shares of the medical instruments supplier’s stock worth $364,000 after buying an additional 143 shares in the last quarter. American Century Companies Inc. grew its stake in shares of Mesa Laboratories by 1.5% in the second quarter. American Century Companies Inc. now owns 13,431 shares of the medical instruments supplier’s stock worth $1,265,000 after acquiring an additional 194 shares in the last quarter. BNP Paribas Financial Markets grew its stake in shares of Mesa Laboratories by 30.9% in the third quarter. BNP Paribas Financial Markets now owns 1,029 shares of the medical instruments supplier’s stock worth $69,000 after acquiring an additional 243 shares in the last quarter. Deutsche Bank AG increased its position in shares of Mesa Laboratories by 5.9% during the fourth quarter. Deutsche Bank AG now owns 4,440 shares of the medical instruments supplier’s stock worth $349,000 after acquiring an additional 248 shares during the period. Finally, Northwestern Mutual Wealth Management Co. increased its position in shares of Mesa Laboratories by 5,366.7% during the fourth quarter. Northwestern Mutual Wealth Management Co. now owns 328 shares of the medical instruments supplier’s stock worth $26,000 after acquiring an additional 322 shares during the period. Hedge funds and other institutional investors own 90.60% of the company’s stock.

About Mesa Laboratories

Mesa Laboratories, Inc (NASDAQ: MLAB) is a global provider of instrumentation products designed for critical process monitoring, testing and calibration. Headquartered in Lakewood, Colorado, the company serves a diverse set of end markets including healthcare, pharmaceutical, food and beverage, energy and industrial sectors. With a focus on precision measurement and validation, Mesa Laboratories helps customers ensure regulatory compliance, product safety and operational efficiency across complex manufacturing and sterilization processes.

The company’s product portfolio encompasses biological and chemical indicators for sterilization process validation, digital data loggers and sensors for environmental monitoring, and optical gas analyzers with sample-conditioning solutions for oil, gas and petrochemical applications.